FSBSI Tomsk National Research Medical Center of the Russian Academy of Sciences

Tomsk 634012

0 studies enrolling now · 1 studies all time

What they study most

Coronary Heart Disease (CHD)

Studies at this site

• Effect of Evolocumab in Patients at High Cardiovascular Risk Without Prior Myocardial Infarction or Stroke — Completed